Indore SEZ exports jump 32 pc due to increased orders from pharma units

Exports from Indore’s Special Economic Zone (SEZ) jumped 32 percent to Rs 8,127.67 crore during the first seven months of the current financial year due to increased orders from pharmaceutical units, an official said on Monday.

According to an official from the Union Ministry of Commerce and Industry, the Indore SEZ, which houses factories manufacturing various products, exported Rs 8,127.67 crore from April-October in the current financial year.

He said in the previous financial year, exports from this SEZ from April to October were worth Rs 6,157.11 crore.

“About 70 percent of exports from the Indore SEZ are pharmaceuticals, and the United States is among the top importers of these drugs,” the official said.

He said the Indore SEZ, spread over 572 hectares in the Pithampur Industrial Area, houses 59 plants in various sectors, including pharmaceuticals, packaging materials, engineering, textile manufacturing, and food processing. Of these, 22 are in the pharmaceutical sector alone.

Related Posts

Gene Therapy for Cholesterol: Initial Test Results Cheer

Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gene Therapy for Cholesterol: Initial Test Results Cheer

Gene Therapy for Cholesterol: Initial Test Results Cheer

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states